bibliographic entry 2515007 [be/2515007]
https://w3id.org/oc/corpus/be/2515007

is a

• bibliographic reference

content

• US Food and Drug Administration. Canagliflozin as an adjunctive treatment to diet and exercise alone or co-administered with other antihyperglycemic agents to improve glycemic control in adults with type 2 diabetes mellitus, Silver Spring; Food and Drug Administration, 2013. http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM334551.pdf. (accessed Aug 30, 2016)

references

• https://w3id.org/oc/corpus/br/2786802